Tengjun Biotechnology Corporation (CE) (TJBH) News

Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 8-K/A - Current report: [Amend]

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 12b-25   SEC File...

Current Report Filing (8-k)

0001499785 false 00000 0001499785 2023-05-03 2023-05-03 iso4217:USD...

Annual Report (10-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM...

Current Report Filing (8-k)

0001499785 false 00000 0001499785 2023-01-09 2023-01-09 iso4217:USD...

Quarterly Report (10-q)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on October 27, 2022 Registration No. 333-266300     UNITED...

Amended Quarterly Report (10-q/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM...